Prostate Cancer Tissue Biomarkers Associated with Tumor Microenvironment and Progression: Application of NMR Spectroscopy

In cancers of men, prostate cancer (PCa) is a prevalent malignancy. Finding biomarkers is important and useful for figuring out PCa incidence and prognosis. For males over 50, prostate cancer (PCa) is the most prevalent adenocarcinoma type of cancer diagnosis. PCa typically has a variety of clinical and pathological symptoms and is heterogeneous and multifocal. There is currently little knowledge about the molecular genetics of the progression mechanism behind this variability. The most effective method for examining unidentified metabolites in biological biomaterials is nuclear magnetic resonance (NMR) spectroscopy. Furthermore, metabolomics is a systems approach that aims to offer information on metabolic abnormalities associated with PCa by analyzing in vitro metabolic profiles.